GB1062357A - Quinazolone derivatives - Google Patents

Quinazolone derivatives

Info

Publication number
GB1062357A
GB1062357A GB32543/65A GB3254365A GB1062357A GB 1062357 A GB1062357 A GB 1062357A GB 32543/65 A GB32543/65 A GB 32543/65A GB 3254365 A GB3254365 A GB 3254365A GB 1062357 A GB1062357 A GB 1062357A
Authority
GB
United Kingdom
Prior art keywords
alkyl
amino
alkenyl
represent
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32543/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB1062357A publication Critical patent/GB1062357A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Abstract

Novel compounds of the general formula <FORM:1062357/C2/1> (wherein R1 and R2 each represent F, Cl, Br, CF3 or a C1- 4 alkyl, alkoxy or alkylthio group or one only of them may represent H, or R1 and R2 jointly represent a 6,7-methylenedioxy or ethylenedioxy radical, and R represents an amino, N-mono- or di-(alkyl, hydroxyalkyl or alkenyl)-amino, N-alkyl-N-(alkenyl, phenyl or p-tolyl)-amino, N-pyrryl, pyrrolidino, piperidino, homopiperidino, morpholino, piperazino, N1-(alkyl, hydroxyalkyl or phenyl)-piperazino or N-(1,2,3,4-tetrahydroisoquinolyl) group, each alkyl and alkenyl group in R containing not more than 5 carbon atoms), and their salts with pharmacologically acceptable acids and bases, are prepared by reacting a corresponding 2-halo-3,4 -dihydroquinazolin-4-one with an amino compound RH, and,if desired, converting the product into a salt by treatment with a nontoxic acid or base. R1,R2 - Substituted - 2 - halo - 3,4 - dihydroquinazolin-4-ones used as starting materials are prepared by treating the corresponding 2,4-dihaloquinazolines with a strong base in an aqueous or aqueous-organic reaction medium. Pharmaceutical preparations.-The quinazolones of the invention possess antihypertensive properties and may be administered orally or parenterally, e.g. in tablets, capsules, lozenges, troches, hard candies, powders, sprays, aqueous suspensions, injectable solutions, elixirs or syrups.
GB32543/65A 1965-03-23 1965-07-29 Quinazolone derivatives Expired GB1062357A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44220565A 1965-03-23 1965-03-23
US57654966A 1966-09-01 1966-09-01
US734770A 1970-01-28 1970-01-28

Publications (1)

Publication Number Publication Date
GB1062357A true GB1062357A (en) 1967-03-22

Family

ID=27358345

Family Applications (3)

Application Number Title Priority Date Filing Date
GB32543/65A Expired GB1062357A (en) 1965-03-23 1965-07-29 Quinazolone derivatives
GB09069/69A Expired GB1174273A (en) 1965-03-23 1967-02-23 Quinazoline Compounds
GB8764/67A Expired GB1174272A (en) 1965-03-23 1967-02-23 Quinazoline Compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB09069/69A Expired GB1174273A (en) 1965-03-23 1967-02-23 Quinazoline Compounds
GB8764/67A Expired GB1174272A (en) 1965-03-23 1967-02-23 Quinazoline Compounds

Country Status (5)

Country Link
US (1) US3609152A (en)
BE (1) BE678216A (en)
DE (1) DE1620127C3 (en)
FR (1) FR5267M (en)
GB (3) GB1062357A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042192A1 (en) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazoquinazolines, agents containing them and their use to combat fungi and animal pests
WO2002053558A1 (en) * 2001-01-02 2002-07-11 F.Hoffman-La Roche Ag Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
WO2004031171A1 (en) 2002-10-01 2004-04-15 Mitsubishi Pharma Corporation Isoquinoline compounds and medicinal use thereof
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
WO2006003150A1 (en) 2004-06-30 2006-01-12 Janssen Pharmaceutica N.V. Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
US7501412B2 (en) 2002-11-22 2009-03-10 Mitsubishi Tanabe Pharma Corporation Isoquinoline compounds and medicinal use thereof
US8168644B2 (en) 2008-03-27 2012-05-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
US8299256B2 (en) 2007-03-08 2012-10-30 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
US8404713B2 (en) 2007-10-26 2013-03-26 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP inhibitors
US8450486B2 (en) 2003-11-20 2013-05-28 Janssen Pharmaceutica, Nv 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
US8524714B2 (en) 2003-11-20 2013-09-03 Janssen Pharmaceutica, Nv 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
US8623884B2 (en) 2004-06-30 2014-01-07 Janssen Pharmaceutica, Nv Quinazolinedione derivatives as PARP inhibitors
US8889866B2 (en) 2008-03-27 2014-11-18 Janssen Pharmaceutica, Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
US8946221B2 (en) 2004-06-30 2015-02-03 Janssen Pharmaceutica, Nv Phthalazine derivatives as PARP inhibitors

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
DE2847693A1 (en) * 1978-11-03 1980-05-22 Hoechst Ag METHOD FOR PRODUCING PYRIMIDO- (6,1-A) -ISOCHINOLIN-2-ONES
US4625026A (en) * 1982-12-30 1986-11-25 Biomeasure, Inc. 2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
JPS6442472A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
US4877790A (en) * 1987-12-15 1989-10-31 Kanebo Limited Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
TW334434B (en) * 1995-05-16 1998-06-21 Kanebo Ltd Novel quinazoline compound and anti-tumor agent
CN1209392C (en) * 2001-05-14 2005-07-06 阿姆诺洼化学有限公司 Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups
EP1407774A1 (en) * 2002-09-10 2004-04-14 LION Bioscience AG 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
EP1398032A1 (en) * 2002-09-10 2004-03-17 PheneX Pharmaceuticals AG 4-Oxo-quinazolines as LXR nuclear receptor binding compounds
NZ561489A (en) * 2005-02-18 2010-10-29 Mitsubishi Tanabe Pharma Corp Salt of proline derivative, solvate thereof, and production method thereof
BRPI0710083A2 (en) 2006-03-31 2011-08-02 Janssen Pharmaceutica Nv benzoimidazol-2-yl pyrimidine and pyrazine chemical entity, pharmaceutical composition and use of these
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
AU2009267159B2 (en) * 2008-06-30 2014-05-15 Janssen Pharmaceutica Nv Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
CA2746220A1 (en) 2008-12-08 2010-07-08 Vm Pharma Llc Compositions of protein receptor tyrosine kinase inhibitors
US8987444B2 (en) * 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
EP2688884A1 (en) * 2011-03-20 2014-01-29 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for its preparation
DE102011113749A1 (en) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonic acid salts heterocyclylamide substituted imidazoles
US8835417B2 (en) * 2011-09-30 2014-09-16 Janssen Pharmaceutica Nv Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone
SG11201405692UA (en) 2012-03-15 2014-10-30 Celgene Avilomics Res Inc Salts of an epidermal growth factor receptor kinase inhibitor
SG11201405691WA (en) 2012-03-15 2014-10-30 Celgene Avilomics Res Inc Solid forms of an epidermal growth factor receptor kinase inhibitor
US20130261134A1 (en) * 2012-03-30 2013-10-03 Boehringer Ingelheim International Gmbh Mesylate salt forms of a potent hcv inhibitor
TW201446745A (en) 2013-02-08 2014-12-16 Celgene Avilomics Res Inc ERK inhibitors and uses thereof
KR102230383B1 (en) 2013-03-06 2021-03-23 얀센 파마슈티카 엔.브이. Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
US8999992B2 (en) 2013-03-15 2015-04-07 Vm Pharma Llc Crystalline forms of tryosine kinase inhibitors and their salts
JP6634016B2 (en) * 2013-12-03 2020-01-22 アムジエン・インコーポレーテツド Pharmaceutically acceptable N- (4-((3- (2-amino-4-pyrimidinyl) -2-pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazineamine Forms of Salts Used and Their Use
TW201613892A (en) 2014-08-13 2016-04-16 Celgene Avilomics Res Inc Forms and compositions of an ERK inhibitor
MA39286A (en) 2014-09-17 2016-03-24 Mundipharma International Corporation Ltd CRYSTALLINE FORMS OF TYROSINE KINASE INHIBITORS AND THEIR SALTS
CN112645932B (en) * 2016-03-22 2022-01-14 江苏豪森药业集团有限公司 Polymorphic forms of an EGFR inhibitor free base or an acid salt thereof, methods of making and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274194A (en) * 1963-03-29 1966-09-20 Miles Lab Quinazolinedione derivatives
US3301855A (en) * 1963-04-22 1967-01-31 Ciba Geigy Corp Derivatives of 4-nu-(2-nu, nu-dimethylaminolower alkyl)-amino quinazoline
GB1053063A (en) * 1963-05-18
US3257400A (en) * 1964-06-10 1966-06-21 Searle & Co 2-amino-5, 6-dihydrobenzo[h]quinazolin-4(3h)-one and congeners

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042192A1 (en) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazoquinazolines, agents containing them and their use to combat fungi and animal pests
WO2002053558A1 (en) * 2001-01-02 2002-07-11 F.Hoffman-La Roche Ag Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
US7091200B2 (en) 2001-01-02 2006-08-15 Syntex U.S.A. Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
WO2004031171A1 (en) 2002-10-01 2004-04-15 Mitsubishi Pharma Corporation Isoquinoline compounds and medicinal use thereof
US7220759B2 (en) 2002-10-01 2007-05-22 Mitsubishi Pharma Corporation Isoquinoline compound and pharmaceutical use thereof
US7459465B2 (en) 2002-10-01 2008-12-02 Mitsubishi Tanabe Pharma Corporation Isoquinoline compound and pharmaceutical use thereof
US7812178B2 (en) 2002-10-01 2010-10-12 Mitsubishi Tanabe Pharma Corporation Isoquinoline compound and pharmaceutical use thereof
US7501412B2 (en) 2002-11-22 2009-03-10 Mitsubishi Tanabe Pharma Corporation Isoquinoline compounds and medicinal use thereof
US8524714B2 (en) 2003-11-20 2013-09-03 Janssen Pharmaceutica, Nv 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
US8450486B2 (en) 2003-11-20 2013-05-28 Janssen Pharmaceutica, Nv 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
US10150757B2 (en) 2004-06-30 2018-12-11 Janssen Pharmaceutica Nv Quinazolinone derivatives as PARP inhibitors
US9255080B2 (en) 2004-06-30 2016-02-09 Janssen Pharmaceutica Nv Quinazolinedione derivatives as PARP inhibitors
WO2006003150A1 (en) 2004-06-30 2006-01-12 Janssen Pharmaceutica N.V. Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
US8623884B2 (en) 2004-06-30 2014-01-07 Janssen Pharmaceutica, Nv Quinazolinedione derivatives as PARP inhibitors
US8623872B2 (en) 2004-06-30 2014-01-07 Janssen Pharmaceutica, Nv Quinazolinone derivatives as PARP inhibitors
US9522905B2 (en) 2004-06-30 2016-12-20 Janssen Pharmaceutica Nv Quinazolinone derivatives as PARP inhibitors
US8946221B2 (en) 2004-06-30 2015-02-03 Janssen Pharmaceutica, Nv Phthalazine derivatives as PARP inhibitors
US8299256B2 (en) 2007-03-08 2012-10-30 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
US8778966B2 (en) 2007-03-08 2014-07-15 Janssen Pharmaceutica, Nv Quinolinone derivatives as PARP and tank inhibitors
US8404713B2 (en) 2007-10-26 2013-03-26 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP inhibitors
US9150540B2 (en) 2008-03-27 2015-10-06 Janssen Pharmaceutica Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
US8889866B2 (en) 2008-03-27 2014-11-18 Janssen Pharmaceutica, Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
US9598396B2 (en) 2008-03-27 2017-03-21 Janssen Pharmaceutica Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
US8168644B2 (en) 2008-03-27 2012-05-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors

Also Published As

Publication number Publication date
US3609152A (en) 1971-09-28
GB1174272A (en) 1969-12-17
GB1174273A (en) 1969-12-17
DE1620127A1 (en) 1970-03-12
DE1620127C3 (en) 1974-10-10
DE1620127B2 (en) 1974-01-17
FR5267M (en) 1967-07-31
BE678216A (en) 1966-09-22

Similar Documents

Publication Publication Date Title
GB1062357A (en) Quinazolone derivatives
HUT61289A (en) Process for producing pyrimidine derivatives of sulfonamides and pharmaceutical compositions comprising same
GB1047935A (en) Substituted piperazines and preparation thereof
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
CA2203274A1 (en) Apolipoprotein-b synthesis inhibitors
GB1374366A (en) Propanol derivatives and a process for their preparation
NO20001402L (en) Substituted chrome derivatives
MY132062A (en) Apolipoprotein-b synthesis inhibitors
IL26473A (en) 1,4-bis(4-pyrimidylaminoalkyl)-piperazines and process for their manufacture
NZ223847A (en) Substituted piperazine derivatives and pharmaceutical compositions
GB1077173A (en) Substituted alkylene piperidines and methods of preparation thereof
GB1087875A (en) Pyrazinoylguanidines
PT87277A (en) PROCESS FOR THE PREPARATION OF NEW BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
IE33862B1 (en) Thiepin and oxepin derivatives,processes for their production and medicaments containing same
IE832581L (en) Piperidinedione derivatives, possessing anti-arrythmic¹activity, for protecting the myocardium, process for their¹preparation and pharmaceutical compositions containing said¹derivatives
GB1106592A (en) New asymmetrically di-n-substituted piperazines and process for their manufacture
GB1363195A (en) Propenylamine derivatives and process for the production thereof
GB991589A (en) Novel [1,2-ª‡]imidazopyridines and a process for the manufacture thereof
GB1495665A (en) Pyrimidines
US3318895A (en) Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
US3410851A (en) Derivatives of flavone
US3167556A (en) Basic derivatives of anilides
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
GB1093187A (en) Dibenzothiadiazepine dioxide derivatives
ES8500923A1 (en) Phenyl-acetic-acid derivatives, their preparation and pharmaceutical compostions containing them.